- Email: [email protected]
PROPHYLACTIC INTRA-AORTIC BALLOON PUMP INSERTION PRIOR TO SURGICAL LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION
A889 JACC March 17, 2015 Volume 65, Issue 10S
Heart Failure and Cardiomyopathies Prophylactic Intra-Aortic Balloon Pump Insertion Prior to Surgical Left Ventricular Assist Device Implantation Poster Contributions Poster Hall B1 Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m. Session Title: Advances in Heart Failure Therapies: From Diuretics to VADs and Transplant Abstract Category: 14. Heart Failure and Cardiomyopathies: Clinical Presentation Number: 1146-219 Authors: Ravi Prasad Avati Nanjundappa, Rajan Patel, Aditya Bansal, Hamang Patel, Daniel Masvidal, Patrick Campbell, Sapna Desai, Stacy Mandras, Tyrone Collins, Christopher White, Hector Ventura, Ochsner Medical Center, New Orleans, LA, USA
Background: Intra-aortic balloon pump (IABP) insertion is becoming a common hemodynamic optimization strategy prior to Left Ventricular Assist Device (LVAD) implantation. Serious potential complications of IABP insertion include bleeding, infection and vascular injury. We aimed to determine if prophylactic IABP insertion in stable LV systolic dysfunction patients, prior to elective surgical LVAD improved outcomes at Ochsner Medical Center (OMC).
Methods: We performed a chart review of LVAD patients at OMC from 2009-2013. Stable patients undergoing elective LVAD placement with or without prophylactic IABP were included. Patients in cardiogenic shock or on percutaneous left ventricular support were excluded. Baseline characteristics and outcome measures of mortality, length of stay (LOS) and renal function were recorded. Univariate analysis was performed on data up to 1 year post implant. Multivariate and Kaplan Meier survival analyses were also performed.
Results: 94 patients met inclusion criteria. 53 patients had prophylactic IABP inserted prior to LVAD. Baseline characteristics including age, gender, race, ejection fraction and MELD score were similar. Prophylactic IABP placement had no effect on in-hospital, 30-day and 1-year mortality, ICU and hospital LOS, renal function, and duration of inotrope/vasopressor use (Table 1).
Conclusion: Prophylactic IABP insertion prior to elective surgical LVAD implantation in hemodynamically stable patients does not improve outcomes.
Heart Failure and Cardiomyopathies Prophylactic Intra-Aortic Balloon Pump Insertion Prior to Surgical Left Ventricular Assist Device Implantation Poster Contributions Poster Hall B1 Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m. Session Title: Advances in Heart Failure Therapies: From Diuretics to VADs and Transplant Abstract Category: 14. Heart Failure and Cardiomyopathies: Clinical Presentation Number: 1146-219 Authors: Ravi Prasad Avati Nanjundappa, Rajan Patel, Aditya Bansal, Hamang Patel, Daniel Masvidal, Patrick Campbell, Sapna Desai, Stacy Mandras, Tyrone Collins, Christopher White, Hector Ventura, Ochsner Medical Center, New Orleans, LA, USA
Background: Intra-aortic balloon pump (IABP) insertion is becoming a common hemodynamic optimization strategy prior to Left Ventricular Assist Device (LVAD) implantation. Serious potential complications of IABP insertion include bleeding, infection and vascular injury. We aimed to determine if prophylactic IABP insertion in stable LV systolic dysfunction patients, prior to elective surgical LVAD improved outcomes at Ochsner Medical Center (OMC).
Methods: We performed a chart review of LVAD patients at OMC from 2009-2013. Stable patients undergoing elective LVAD placement with or without prophylactic IABP were included. Patients in cardiogenic shock or on percutaneous left ventricular support were excluded. Baseline characteristics and outcome measures of mortality, length of stay (LOS) and renal function were recorded. Univariate analysis was performed on data up to 1 year post implant. Multivariate and Kaplan Meier survival analyses were also performed.
Results: 94 patients met inclusion criteria. 53 patients had prophylactic IABP inserted prior to LVAD. Baseline characteristics including age, gender, race, ejection fraction and MELD score were similar. Prophylactic IABP placement had no effect on in-hospital, 30-day and 1-year mortality, ICU and hospital LOS, renal function, and duration of inotrope/vasopressor use (Table 1).
Conclusion: Prophylactic IABP insertion prior to elective surgical LVAD implantation in hemodynamically stable patients does not improve outcomes.